Neonc Technologies Holdings (NTHI) Operating Expenses (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Operating Expenses of $7.1 million for Q1 2026, down 77.91% year-over-year from $31.9 million in Q1 2025, and down 48.49% quarter-over-quarter from $13.7 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Operating Expenses (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Operating Expenses for 3 consecutive years, with $7.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 77.91% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $33.4 million (down 11.12% YoY), while the FY2025 annual figure was $58.3 million, up 706.59% from the prior year.
- Operating Expenses slipped to $7.1 million in Q1 2026 per NTHI's latest filing, from $13.7 million in the prior quarter.
- Across five years, Operating Expenses topped out at $31.9 million in Q1 2025 and bottomed at $1.3 million in Q2 2024.
- Historically, Operating Expenses has averaged $8.1 million across 3 years, with a median of $5.7 million in 2025.
- Annual changes were most pronounced in 2025 — Operating Expenses jumped 1903.21% — and 2026, when it plunged 77.91%.
- Neonc Technologies Holdings' Operating Expenses stood at $2.1 million in 2024, then soared by 541.92% to $13.7 million in 2025, then tumbled by 48.49% to $7.1 million in 2026.
- Business Quant data shows NTHI's Operating Expenses at $7.1 million in Q1 2026, $13.7 million in Q4 2025, and $6.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 14.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.07 Mn |
| Mar 31, 2026 | 7.06 Mn |
| Dec 31, 2025 | 13.70 Mn |
| Sep 30, 2025 | 6.93 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Mar 31, 2025 | 31.94 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.59 Mn |